THCB Spotlights: Jeremy Orr, CEO of Medial EarlySign

Share:

Share on twitter
Share on linkedin
Share on facebook
Share on email
the health care blog

THCB Spotlights: Jeremy Orr, CEO of Medial EarlySign

Today on THCB Spotlights, Matthew speaks with Jeremy Orr, CEO of Medial EarlySign. Medial EarlySign does complex algorithmic detection of elevated risk trajectories for high-burden serious diseases, and the progression towards chronic diseases such as diabetes. Tune in to hear more about this AI/ML company that has been working on their algorithms since before many had even heard about machine learning, what they’ve been doing with Kaiser Permanente and Geisinger, and where they are going next.

 

Filmed at the HLTH Conference in Las Vegas, October 2019.

 

 

Click here to see the original interview

Share:

Share on twitter
Share on linkedin
Share on facebook
Share on email

Are you looking to solve high-burden disease challenges?